Abstract:Objectives Resistant hypertension (RH) is a common clinical problem, but the exact prevalence of RH is unknown. Recently, data from the National Health and Nutrition Examination Survey indicated that the prevalence of RH was 12.8% in the USA. It is noticeable that the prevalence of RH in China has not been reported. The aims of the study were to investigate the prevalence of RH in an urban community and the outpatient departments of cardiology of a tertiary hospital in Chengdu, which is located in West China. Methods From 2011 to 2012, 2740 adults with hypertension from the outpatient departments of cardiology of a tertiary hospital were sequentially evaluated and 583 adults with hypertension from an urban community were recruited by random sampling method. Definition of RH was established by JNC7, described as failure to achieve goal BP (<140/90 mmHg in the general hypertensive population and <130/80 mmHg in patients with diabetes or chronic kidney disease) when patients adhere to full doses of an appropriate regimen of 3 antihypertensive drugs, including a diuretic. Results In 2740 patients from the outpatient departments, 2257 (82.4%) were taking medications for hypertension. In 583 patients from community, 331 (56.8%) were taking anti-hypertension medications. The prevalence of RH in the antihypertensive drug–treated patients was 1.8% in the community (2.0% for men, 1.7% for women, respectively) and 7.0% in the outpatient departments (7.2% for men, 6.7% for women, respectively) (P < 0.001, between the community and the outpatient departments). To compare with figures in the USA, we redone statistics on the basis of RH definition they adopted (if blood pressure was ≥ 140/90 mmHg and using antihypertensive medications from 3 different drug classes or using drugs from ≥ 4 antihypertensive drug classes regardless of blood pressure). The prevalence of RH was then rised to 4.2% in the community (5.3% for men, 3.9% for women, respectively) and 13.5% in the outpatient departments (13.4% for men, 13.5% for women, respectively) (P < 0.001, between the community and the outpatient departments). Comparing the types of antihypertensive medications used by patients with RH, use of diuretics in our clinic is significantly lower than in the USA (51% vs 85.6%, P < 0.001). Conclusions The prevalence of RH in the general population was evidently lower in West China than in the USA. As a key drug for treating RH, the use of diuretics was lower in West China than in the USA, while, the prevalence of RH was evidently lower in West China than in the USA, which might be explained by ethnic difference.

A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region: the spirit study

A7958 Prevalence and Clinical Characteristics of Patients with Treatment Resistant Hypertension by Region

Clinical Characteristics, Antihypertensive Medication Use and Blood Pressure Control among Patients with Treatment-Resistant Hypertension: the Survey of PatIents with Treatment ResIstant Hypertension Study

Prevalence of Pragmatically Defined High CV Risk and its Correlates in LMIC: A Report From 10 LMIC Areas in Africa, Asia, and South America.

Apparent treatment-resistant hypertension: characteristics and prevalence in a real-world environment of an integrated health system.

Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study

Apparent Treatment-Resistant Hypertension Across the Spectrum of Heart Failure Phenotypes in the Swedish HF Registry

The Prevalence and Clinical Characteristics of Apparent and True Resistant Hypertension

Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: A multi-center cross-sectional study

Prevalence, Treatment, and Control Rates of Conventional and Ambulatory Hypertension Across 10 Populations in 3 Continents

Impact of psychological profile on drug adherence and drug resistance in patients with apparently treatment-resistant hypertension

Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program

Hypertension, uncontrolled hypertension and resistant hypertension: prevalence, comorbidities and prescribed medications in 228,406 adults resident in urban areas. A population-based observational study

Prevalence of refractory hypertension in the United States from 1999 to 2014.

Resistant hypertension: diagnosis, evaluation, and treatment a clinical consensus statement from the Thai hypertension society

Prevalence of true resistant hypertension in those referred for uncontrolled hypertension in Malaysia: A comparison using different definitions

Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study

GW24-e2939 Prevalence of Resistant Hypertension in West China

Social Determinants of Health and Incident Apparent Treatment-Resistant Hypertension Among White and Black US Adults: The REGARDS Study

Whole genome sequence analysis of apparent treatment resistant hypertension status in participants from the Trans-Omics for Precision Medicine program

Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: A 10/66 cross-sectional population-based survey